{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:23:23Z","timestamp":1786991003224,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202401156ZYTS"],"award-info":[{"award-number":["YDZJ202401156ZYTS"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116326","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T22:17:39Z","timestamp":1770848259000},"page":"116326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["NGR-modified cancer-associated fibroblast-derived exosomes deliver resveratrol to inhibit CXCR2\/NF-\u03baB signaling in myeloid-derived suppressor cells and reverse immune suppression in liver cancer"],"prefix":"10.1016","volume":"174","author":[{"given":"Lijuan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116326_bb0005","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116326_bb0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116326_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00109-015-1376-x","article-title":"Immunosuppressive cells in tumor immune escape and metastasis","volume":"94","author":"Liu","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116326_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03966-7","article-title":"Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation","volume":"9","author":"Taki","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116326_bb0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022015418","article-title":"CXCL8\/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis","author":"Dunbar","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116326_bb0030","article-title":"Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy","volume":"5","author":"Li","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2026.116326_bb0035","first-page":"1786","article-title":"Alcohol remodels the immunosuppressive tumor microenvironment by targeting myeloid-derived suppressor cells","volume":"13","author":"Li","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116326_bb0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.37349\/etat.2024.00236","article-title":"Anti-PD-1\/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis","volume":"5","author":"Zhou","year":"2024","journal-title":"Explor. Target. Anti-Tumor Ther."},{"key":"10.1016\/j.intimp.2026.116326_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116326_bb0050","article-title":"Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer","volume":"14","author":"He","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.intimp.2026.116326_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/JLB.3MR0320-444R","article-title":"Natural products and their derivatives: promising modulators of tumor immunotherapy","volume":"108","author":"Deng","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.116326_bb0060","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2174\/1568026623666230201145909","article-title":"Tumor-associated macrophages (TAMs) in cancer resistance; modulation by natural products","volume":"23","author":"Lafta","year":"2023","journal-title":"CTMC"},{"key":"10.1016\/j.intimp.2026.116326_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jox11010002","article-title":"The effects of resveratrol on prostate cancer through targeting the tumor microenvironment","volume":"11","author":"Silk","year":"2021","journal-title":"JoX"},{"key":"10.1016\/j.intimp.2026.116326_bb0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/ijms20040925","article-title":"Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer","volume":"20","author":"Han","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2026.116326_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578069","article-title":"A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-\u03baB and notch inflammatory signaling in the BTBR mouse model of autism","volume":"377","author":"Alomar","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2026.116326_bb0080","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/ijms21062084","article-title":"Potential adverse effects of resveratrol: a literature review","volume":"21","author":"Shaito","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2026.116326_bb0085","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1021\/acs.jafc.1c02602","article-title":"Dual strategy for improving the Oral bioavailability of resveratrol: enhancing water solubility and inhibiting glucuronidation","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.116326_bb0090","article-title":"The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116326_bb0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12094-021-02731-5","article-title":"Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer","volume":"24","author":"Cheuk","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.intimp.2026.116326_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116326_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.116326_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116326_bb0115","article-title":"Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.intimp.2026.116326_bb0120","first-page":"113","article-title":"Application of Asn-Gly-Arg sequence based cyclic peptides for targeted tumor therapy","volume":"65","author":"Mez\u0151","year":"2021","journal-title":"Magy. Onkol."},{"key":"10.1016\/j.intimp.2026.116326_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/1536012120934957","article-title":"Research progress of radiolabeled Asn-Gly-Arg (NGR) peptides for imaging and therapy","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.intimp.2026.116326_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122618","article-title":"Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer","volume":"633","author":"Conte","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2026.116326_bb0135","article-title":"Responsive dual-targeting exosome as a drug carrier for combination","volume":"2021","author":"Fan","year":"2021","journal-title":"Cancer Immunother. Res."},{"key":"10.1016\/j.intimp.2026.116326_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114195","article-title":"Peptide-targeted nanoparticles for tumor therapy","volume":"387","author":"Sidorenko","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116326_bb0145","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.116326_bb0150","article-title":"A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy","volume":"8","author":"Zhang","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.intimp.2026.116326_bb0155","doi-asserted-by":"crossref","DOI":"10.34133\/research.0749","article-title":"Radiomic model associated with tumor microenvironment predicts immunotherapy response and prognosis in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"8","author":"Sun","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.intimp.2026.116326_bb0160","first-page":"167","article-title":"Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB\/c mouse through reducing myeloid-derived suppressor cells","volume":"25","author":"Su","year":"2015","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.intimp.2026.116326_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0674-1","article-title":"Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells","volume":"7","author":"Apodaca","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.116326_bb0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116326_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/imr.12205","article-title":"The interface between transcriptional and epigenetic control of effector and memory CD8+ T-cell differentiation","volume":"261","author":"Gray","year":"2014","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2026.116326_bb0180","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.34067\/KID.0000000947","article-title":"NF erythroid 2-related factor 2 deficiency enhances the immunosuppressive function of monocytic myeloid-derived suppressor cells in a peroxisome proliferator-activated receptor-\u03b3-dependent manner","volume":"360","author":"Jia","year":"2025","journal-title":"Kidney"},{"key":"10.1016\/j.intimp.2026.116326_bb0185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/2326-6066.CIR-20-0433","article-title":"Targeting PIM1-mediated metabolism in myeloid suppressor cells to treat cancer","volume":"9","author":"Xin","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.116326_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02594-2","article-title":"Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting protein","volume":"22","author":"Jin","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.intimp.2026.116326_bb0195","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1073\/pnas.1102434108","article-title":"Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins","volume":"109","author":"Liberal","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116326_bb0200","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/1878-0261.13052","article-title":"iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation","volume":"15","author":"Lin","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2026.116326_bb0205","first-page":"265","article-title":"Establishment of an immunological tolerance model in BALB\/C mice and a preliminary study on transplantation of human lung tumors","volume":"13","author":"Ren","year":"2001","journal-title":"Carcinogenesis Teratogenesis Mutagenesis"},{"key":"10.1016\/j.intimp.2026.116326_bb0210","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.21037\/tlcr-2024-1272","article-title":"Synergistic anti-tumor effect of fenbendazole and diisopropylamine dichloroacetate in immunodeficient BALB\/c nude mice transplanted with A549 lung cancer cells","volume":"14","author":"Nguyen","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.intimp.2026.116326_bb0215","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2018.9720","article-title":"Inhibition of colorectal cancer liver metastasis in BALB\/c mice following intratumoral injection of oncolytic herpes simplex virus type 2 for the induction of specific antitumor immunity","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2026.116326_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117526","article-title":"Targeting CXCR2 ameliorated tacrolimus-induced nephrotoxicity by alleviating overactivation of PI3K\/AKT\/mTOR pathway and calcium overload","volume":"180","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116326_bb0225","article-title":"Breaking barriers: targeted delivery of resveratrol in lung cancer using folate-integrated and pH-responsive hybrid nanocarriers","volume":"11","author":"Das","year":"2025","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2026.116326_bb0230","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.5417","article-title":"Rapid isolation and flow cytometry analysis of murine intestinal immune cells after chemically induced colitis","volume":"15","author":"Singh","year":"2025","journal-title":"Bio-Protocol."},{"key":"10.1016\/j.intimp.2026.116326_bb0235","article-title":"Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116326_bb0240","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3892\/or.2017.5347","article-title":"Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway","volume":"37","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2026.116326_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116225","article-title":"ADSC-exos enhance functional recovery after spinal cord injury by inhibiting ferroptosis and promoting the survival and function of endothelial cells through the NRF2\/SLC7A11\/GPX4 pathway","volume":"172","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116326_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-020-02064-6","article-title":"Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer","volume":"21","author":"Chen","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2026.116326_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02243","article-title":"S100A9 regulates MDSCs-mediated immune suppression via the RAGE and TLR4 signaling pathways in colorectal carcinoma","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116326_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116326_bb0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116326_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","article-title":"CXCR2 chemokine receptor \u2013 a master regulator in cancer and physiology","volume":"30","author":"Lazennec","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2026.116326_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115175","article-title":"Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers","volume":"250","author":"Xie","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116326_bb0280","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","article-title":"CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 axis to enhance efficacy against pancreatic cancer","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116326_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115275","article-title":"Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-\u03baB signaling","volume":"165","author":"Ma","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116326_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/1097706","article-title":"Therapeutic role and potential mechanism of resveratrol in atherosclerosis: TLR4\/NF-\u03baB\/HIF-1\u03b1","volume":"2023","author":"Guo","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2026.116326_bb0295","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3390\/nu7064383","article-title":"Resveratrol inhibits the invasion of glioblastoma-initiating cells via down-regulation of the PI3K\/Akt\/NF-\u03baB Signaling pathway","volume":"7","author":"Jiao","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.116326_bb0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2023.09.037","article-title":"Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery","volume":"363","author":"Meng","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116326_bb0305","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/pharmaceutics15072011","article-title":"Bio-inspired nanocarriers derived from stem cells and their extracellular vesicles for targeted drug delivery","volume":"15","author":"Abudurexiti","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116326_bb0310","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into Tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116326_bb0315","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2174\/138920111796117373","article-title":"Tumor vasculature targeting through NGR peptide-based drug delivery systems","volume":"12","author":"Corti","year":"2011","journal-title":"CPB"},{"key":"10.1016\/j.intimp.2026.116326_bb0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nri2972","article-title":"Overcoming hurdles in developing successful drugs targeting chemokine receptors","volume":"11","author":"Schall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116326_bb0325","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318534121","article-title":"CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance","volume":"121","author":"Banuelos","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116326_bb0330","article-title":"Microglial polarization in TBI: signaling pathways and influencing pharmaceuticals","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.116326_bb0335","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2017.12.026","article-title":"LXR\/ApoE activation restricts innate immune suppression in cancer","volume":"172","author":"Tavazoie","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116326_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1196312","article-title":"Improving cancer immunotherapy by targeting the STATe of MDSCs","volume":"5","author":"de Haas","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.intimp.2026.116326_bb0345","article-title":"TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8+ T cell activation","volume":"16","author":"Wei","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116326_bb0350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304689120","article-title":"MHC class Ib\u2013restricted CD8 + T cells possess strong tumoricidal activities","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116326_bb0355","first-page":"56","article-title":"Incidence of hyper progressive disease in combination immunotherapy and anti-programmed cell death protein 1\/programmed death-ligand 1 monotherapy for unresectable hepatocellular carcinoma, liver","volume":"13","author":"Aoki","year":"2023","journal-title":"Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:33:19Z","timestamp":1775305999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":71,"alternative-id":["S1567576926001700"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116326","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NGR-modified cancer-associated fibroblast-derived exosomes deliver resveratrol to inhibit CXCR2\/NF-\u03baB signaling in myeloid-derived suppressor cells and reverse immune suppression in liver cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116326"}}